Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to 0.01.

  • Avidity Biosciences' Asset Utilization Ratio rose 75.95% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 75.95%. This contributed to the annual value of 0.01 for FY2024, which is 34.11% down from last year.
  • As of Q3 2025, Avidity Biosciences' Asset Utilization Ratio stood at 0.01, which was up 57.02% from 0.01 recorded in Q2 2025.
  • Avidity Biosciences' Asset Utilization Ratio's 5-year high stood at 0.03 during Q2 2021, with a 5-year trough of 0.01 in Q1 2025.
  • For the 3-year period, Avidity Biosciences' Asset Utilization Ratio averaged around 0.01, with its median value being 0.01 (2025).
  • Per our database at Business Quant, Avidity Biosciences' Asset Utilization Ratio slumped by 60.45% in 2024 and then soared by 75.95% in 2025.
  • Over the past 5 years, Avidity Biosciences' Asset Utilization Ratio (Quarterly) stood at 0.02 in 2021, then decreased by 21.06% to 0.02 in 2022, then fell by 7.77% to 0.02 in 2023, then slumped by 57.26% to 0.01 in 2024, then surged by 75.95% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.01 for Q2 2025, and 0.01 during Q1 2025.